Type-3 Metabotropic Glutamate Receptors and Parkinson's Disease: Preclinical Studies and Human Genetics

被引：0
|
作者：
Alborghetti, M. [1 ]
Di Menna, L. [1 ]
Traficante, A. [1 ]
Bruno, V. [1 ]
Monn, J. [1 ]
Nicoletti, F. [1 ]
Pontieri, F. E. [1 ]
Bianchini, E. [1 ]
Spalletta, G. [1 ]
Borro, M. [1 ]
Simmaco, M. [1 ]
Battaglia, G. [1 ]
机构：
[1] Neurosci Mental Hlth & Sensory Organs NESMOS, Rome, Italy
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
523
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [41] mGlu3 receptors in Parkinson's disease as a candidate target for neuroprotective therapy: evidence from preclinical studies to human genetic
    Alborghetti, M.
    Di Menna, L.
    Bruno, V.
    Battaglia, G.
    Pontieri, F. E.
    Bianchini, E.
    Simmaco, M.
    Borro, M.
    Nicoletti, F.
    MOVEMENT DISORDERS, 2022, 37 : S660 - S660
  • [42] Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease
    Caraci, Filippo
    Nicoletti, Ferdinando
    Copani, Agata
    CURRENT OPINION IN PHARMACOLOGY, 2018, 38 : 1 - 7
  • [43] Glutamate receptors and Parkinson's disease - Opportunities for intervention
    Marino, MJ
    Valenti, O
    Conn, PJ
    DRUGS & AGING, 2003, 20 (05) : 377 - 397
  • [44] Glutamate Receptors as Therapeutic Targets for Parkinson's Disease
    Johnson, Kari A.
    Conn, P. Jeffrey
    Niswender, Colleen M.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 475 - 491
  • [45] Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas
    Ciceroni, C.
    Bonelli, M.
    Mastrantoni, E.
    Niccolini, C.
    Laurenza, M.
    Larocca, L. M.
    Pallini, R.
    Traficante, A.
    Spinsanti, P.
    Ricci-Vitiani, L.
    Arcella, A.
    De Maria, R.
    Nicoletti, F.
    Battaglia, G.
    Melchiorri, D.
    CELL DEATH AND DIFFERENTIATION, 2013, 20 (03): : 396 - 407
  • [46] Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas
    C Ciceroni
    M Bonelli
    E Mastrantoni
    C Niccolini
    M Laurenza
    L M Larocca
    R Pallini
    A Traficante
    P Spinsanti
    L Ricci-Vitiani
    A Arcella
    R De Maria
    F Nicoletti
    G Battaglia
    D Melchiorri
    Cell Death & Differentiation, 2013, 20 : 396 - 407
  • [47] Density of metabotropic glutamate receptors subtype 1 in Parkinson's disease compared to healthy elderly - a ITMM PET study -
    Mishina, M.
    Suzuki, M.
    Ishii, K.
    Sakata, M.
    Wagatsuma, K.
    Ishibashi, K.
    Toyohara, J.
    Zhang, M. R.
    Kimura, K.
    Ishiwata, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 806 - 807
  • [48] Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease
    Lopez, Sebastien
    Turle-Lorenzo, Nathalie
    Acher, Francine
    De Leonibus, Elvira
    Mele, Andrea
    Amalric, Marianne
    JOURNAL OF NEUROSCIENCE, 2007, 27 (25): : 6701 - 6711
  • [49] Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model
    Hsieh, Ming-Hong
    Ho, Shih-Chun
    Yeh, Kuei-Ying
    Pawlak, Cornelius Rainer
    Chang, Hung-Ming
    Ho, Ying-Jui
    Lai, Te-Jen
    Wu, Fu-Ying
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 102 (01) : 64 - 71
  • [50] In vivo characterization of metabotropic glutamate 2 and 5 receptors in Alzheimer's Disease
    Yuan, Gengyang
    Neelamegam, Ramesh
    Lule, Sevda
    Pan, Chuzhi
    Qu, Xiying
    Brownell, Anna-Liisa
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345